Estimate Recalculated Apr 2, 2025 08:06PM EST
Carole Ho has an estimated net worth of $5.82 Million. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, Denali Therapeutics Inc., and Beam Therapeutics Inc..
Carole Ho's CIK is 0001724605
2019 was Carole Ho's most active year for acquiring shares with 25 total transactions. Carole Ho's most active month to acquire stocks was the month of December. 2019 was Carole Ho's most active year for disposing of shares, totalling 63 transactions. Carole Ho's most active month to dispose stocks was the month of March. 2019 saw Carole Ho paying a total of $506,637.12 for 254,597 shares, this is the most they've acquired in one year. In 2024 Carole Ho cashed out on 195,415 shares for a total of $765,337.37, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
| Form 4 | -100.00% | -161.76K | — | — | Apr 08, 2024 | — | Disposition | — | Apr 05 | 
| Form 4 | — | 78.41K | — | — | May 12, 2023 | 78.41K | Grant | — | May 10 | 
| Form 4 | — | 24.22K | — | — | May 20, 2022 | 24.22K | Grant | — | May 18 | 
| Form 4 | — | 19.62K | — | — | Jun 10, 2021 | 19.62K | Grant | — | Jun 08 | 
| Form 4 | — | 39.52K | — | — | Jun 09, 2020 | 39.52K | Grant | — | Jun 05 | 
| Form 3 | — | — | — | — | Jun 09, 2020 | — | — | — | — | 
| Form 4 | -15.90% | -22.46K | $24.49 | -$549.93K | Aug 22, 2024 | 327.03K | Sale | Scheduled | Aug 20 - Aug 21 | 
| Form 4 | -1.63% | -2.34K | $22.89 | -$53.49K | Aug 15, 2024 | 349.49K | Sale | — | Aug 13 | 
| Form 4 | -2.83% | -4.19K | $17.46 | -$73.13K | Feb 15, 2024 | 351.82K | Sale | Scheduled | Feb 13 - Feb 14 | 
| Form 4 | -3.06% | -4.67K | $19.02 | -$88.79K | Jan 12, 2024 | 356.01K | Sale | Scheduled | Jan 10 | 
| Form 4 | -4.78% | -9.97K | $19.43 | -$193.76K | Jan 09, 2024 | 360.68K | Sale | — | Jan 05 | 
| Form 4 | 197.66% | 214.88K | — | — | Jan 05, 2024 | 531.81K | Grant | — | Jan 03 | 
| Form 4 | -1.36% | -2.52K | $23.22 | -$58.56K | Aug 25, 2023 | 316.93K | Sale | — | Aug 23 | 
| Form 4 | -1.32% | -2.48K | $22.60 | -$56.00K | Aug 23, 2023 | 319.46K | Sale | — | Aug 21 | 
| Form 4 | -1.49% | -2.77K | $23.79 | -$65.85K | Aug 16, 2023 | 321.93K | Sale | — | Aug 14 | 
| Form 4 | -1.52% | -2.86K | $24.15 | -$69.00K | Aug 14, 2023 | 324.70K | Sale | — | Aug 10 | 
| Form 4 | -0.80% | -1.48K | $29.40 | -$43.39K | Feb 17, 2023 | 327.56K | Sale | Scheduled | Feb 15 | 
| Form 4 | -0.92% | -3.37K | $29.95 | -$101.07K | Feb 14, 2023 | 508.40K | Sale | Scheduled | Feb 10 - Feb 13 | 
| Form 4 | -0.84% | -1.52K | $30.88 | -$46.97K | Feb 10, 2023 | 332.40K | Sale | — | Feb 08 | 
| Form 4 | -0.82% | -1.46K | $28.48 | -$41.55K | Jan 10, 2023 | 333.92K | Sale | Scheduled | Jan 09 | 
| Form 4 | -2.23% | -4.09K | $28.52 | -$116.57K | Jan 09, 2023 | 335.38K | Sale | Scheduled | Jan 05 - Jan 06 | 
| Form 4 | 58.48% | 161.57K | $28.69 | -$83.57K | Jan 05, 2023 | 462.83K | Grant | — | Jan 03 - Jan 04 | 
| Form 4 | -1.40% | -2.42K | $31.98 | -$77.52K | Aug 25, 2022 | 301.26K | Sale | Scheduled | Aug 23 | 
| Form 4 | -1.47% | -2.58K | $33.22 | -$85.57K | Aug 23, 2022 | 303.68K | Sale | — | Aug 19 | 
| Form 4 | 25.54% | 22.50K | — | — | Aug 11, 2022 | 306.26K | Grant | — | Aug 09 | 
| Form 4 | -1.68% | -2.92K | $34.71 | -$101.28K | Feb 15, 2022 | 283.76K | Sale | — | Feb 11 | 
| Form 4 | -0.85% | -1.42K | $37.10 | -$52.79K | Feb 11, 2022 | 286.68K | Sale | — | Feb 09 | 
| Form 4 | -1.71% | -2.85K | $44.78 | -$127.40K | Jan 07, 2022 | 288.10K | Sale | — | Jan 05 | 
| Form 4 | 162.48% | 124.00K | — | — | Jan 05, 2022 | 383.95K | Grant | — | Jan 03 | 
| Form 4 | -1.90% | -1.48K | $42.52 | -$62.76K | Dec 08, 2021 | 259.95K | Sale | Scheduled | Dec 06 | 
| Form 4 | -3.73% | -6.14K | $48.91 | -$300.45K | Aug 25, 2021 | 261.42K | Sale | Scheduled | Aug 23 | 
| Form 4 | -1.52% | -2.55K | $49.58 | -$126.23K | Aug 23, 2021 | 267.57K | Sale | — | Aug 19 | 
| Form 4 | -1.71% | -2.82K | $54.62 | -$154.13K | Mar 31, 2021 | 269.70K | Sale | Scheduled | Mar 29 | 
| Form 4 | -4.12% | -7.09K | $66.38 | -$470.74K | Mar 03, 2021 | 272.52K | Sale | Scheduled | Mar 01 | 
| Form 4 | -1.80% | -3.16K | $70.33 | -$221.97K | Feb 16, 2021 | 279.62K | Sale | — | Feb 11 | 
| Form 4 | -0.83% | -1.47K | $74.68 | -$109.78K | Feb 11, 2021 | 202.90K | Sale | — | Feb 07 - Feb 09 | 
| Form 4 | — | 120.00K | — | — | Jan 06, 2021 | 120.00K | Grant | — | Jan 04 | 
| Form 4/A | -6.67% | -17.50K | $12.36 | -$247.77K | Nov 30, 2020 | 316.88K | Sale | Scheduled | Jan 02 - Jan 04 | 
| Form 4/A | 7.14% | 17.50K | $11.87 | -$230.43K | Nov 30, 2020 | 334.38K | Sell-Options | Scheduled | Dec 03 | 
| Form 4/A | -5.88% | -17.50K | $11.68 | -$251.56K | Nov 30, 2020 | 351.88K | Sale | Scheduled | Nov 15 | 
| Form 4 | -17.53% | -52.91K | $23.01 | -$1.88M | Oct 13, 2020 | 273.89K | Sale | Scheduled | Oct 08 - Oct 09 | 
| Form 4 | -2.19% | -3.69K | $31.00 | -$114.36K | Sep 14, 2020 | 190.14K | Sale | Scheduled | Sep 10 | 
| Form 4 | -23.08% | -1.95K | $32.88 | -$64.25K | Aug 24, 2020 | 158.32K | Options | — | Aug 20 - Aug 21 | 
| Form 4 | — | 20.00K | — | — | Aug 20, 2020 | 20.00K | Grant | — | Aug 18 | 
| Form 4 | -33.60% | -1.43K | $19.48 | -$27.82K | Apr 01, 2020 | 154.63K | Sale | — | Mar 30 | 
| Form 4/A | — | — | — | — | Apr 01, 2020 | 17.00K | Options | — | Feb 07 | 
| Form 4 | — | 171.87K | — | — | Feb 12, 2020 | 171.87K | Grant | — | Feb 10 | 
| Form 4 | -100.00% | -6.89K | $20.01 | -$137.83K | Dec 23, 2019 | 151.81K | Sale | Scheduled | Dec 19 - Dec 23 | 
| Form 4 | -4.87% | -2.83K | $18.59 | -$52.67K | Aug 22, 2019 | 160.26K | Options | — | Aug 20 - Aug 21 | 
| Form 4 | -6.43% | -17.50K | $12.79 | -$320.63K | Jul 10, 2019 | 326.58K | Sale | Scheduled | Jul 08 | 
| Form 4 | -6.13% | -17.50K | $12.03 | -$304.28K | Jun 12, 2019 | 340.00K | Sale | Scheduled | Jun 10 | 
| Form 4 | -8.44% | -17.50K | $14.07 | -$358.65K | May 10, 2019 | 261.62K | Sale | Scheduled | May 08 - May 10 | 
| Form 4/A | -14.55% | -36.91K | $15.36 | -$844.57K | May 10, 2019 | 288.71K | Sale | Scheduled | Apr 01 - Apr 03 | 
| Form 4 | -7.79% | -9.59K | $26.35 | -$252.68K | Apr 08, 2019 | 185.37K | Sale | Scheduled | Apr 04 | 
| Form 4 | -19.13% | -48.53K | $14.13 | -$904.35K | Apr 03, 2019 | 288.82K | Sale | Scheduled | Apr 01 - Apr 03 | 
| Form 4 | -0.39% | -1.00K | $15.15 | -$22.37K | Mar 18, 2019 | 325.62K | Sale | Scheduled | Mar 14 | 
| Form 4 | -13.50% | -17.50K | $13.73 | -$295.60K | Mar 05, 2019 | 326.62K | Sale | Scheduled | Mar 01 - Mar 05 | 
| Form 4 | — | 153.00K | — | — | Feb 11, 2019 | 153.00K | Grant | — | Feb 07 | 
| Form 4 | -7.20% | -17.50K | $12.00 | -$235.19K | Feb 05, 2019 | 440.00K | Sale | Scheduled | Feb 01 - Feb 05 | 
| Form 4 | -5.35% | -14.50K | $12.42 | -$221.60K | Jan 04, 2019 | 328.20K | Sale | Scheduled | Jan 02 - Jan 04 | 
| Form 4 | -10.55% | -17.50K | $18.45 | -$322.83K | Dec 06, 2018 | 220.27K | Sale | Scheduled | Dec 03 | 
| Form 4 | -9.54% | -17.50K | $18.07 | -$316.16K | Nov 19, 2018 | 237.77K | Sale | Scheduled | Nov 15 | 
| Form 4 | -8.71% | -17.50K | $21.72 | -$380.10K | Oct 03, 2018 | 255.27K | Sale | Scheduled | Oct 01 | 
| Form 4 | -8.01% | -17.50K | $19.05 | -$333.37K | Sep 06, 2018 | 272.77K | Sale | Scheduled | Sep 04 | 
| Form 4 | -7.42% | -17.50K | $18.04 | -$315.70K | Aug 31, 2018 | 290.27K | Sale | Scheduled | Aug 29 | 
| Form 4 | — | 11.29K | — | — | Aug 22, 2018 | 11.29K | Grant | — | Aug 20 | 
| Form 4 | — | 180.00K | — | — | Feb 28, 2018 | 180.00K | Grant | — | Feb 26 | 
| Form 3 | — | — | — | — | Dec 07, 2017 | 307.77K | — | — | — | 
| Form 4 | — | 23.11K | — | — | Jun 07, 2024 | 23.11K | Grant | — | Jun 05 | 
| Form 4 | — | 16.53K | — | — | Jun 08, 2023 | 16.53K | Grant | — | Jun 06 | 
| Form 4 | — | 10.39K | — | — | Sep 02, 2022 | 10.39K | Grant | — | Sep 01 | 
| Form 4 | — | 6.88K | — | — | Jun 14, 2021 | 6.88K | Grant | — | Jun 10 | 
| Form 3 | — | — | — | — | Feb 05, 2020 | — | — | — | — |